97
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Biomarkers of oral exposure to 3-nitro-1,2,4-triazol-5-one (NTO) and 2,4-dinitroanisole (DNAN) in blood and urine of rhesus macaques (Macaca mulatta)

, , , , , & show all
Pages 587-594 | Received 18 Jul 2013, Accepted 24 Jul 2013, Published online: 03 Sep 2013

References

  • Agency for Toxic Substances and Disease Registry (ATSDR). (1995). Toxicological Profile for Dinitrophenol. Atlanta (GA): ATSDR. [online]. Available from: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=729&tid=132 [last accessed 1 Jul 2013]
  • Beauregard RL. (2011). The History of Insensitive Munitions, Arras Word Press Theme. Available from: http://www.insensitivemunitions.org/ [last accessed 1 Jul 2013]
  • Crouse L. (2010). Subchronic oral toxicity of 3-nitro-1,2,4-triazol-5-one (NTO) in rats. Aberdeen Proving Ground (MD): U.S. Army Public Health Command
  • Duncan K. (2002). Insensitive Munitions and the Army: improving safety and survivability. Army Logistician 31:16–17
  • Eiseman JL, Gehring PJ, Gibson JE. (1972). The in vitro metabolism of 2,4-dinitrophenol by rat liver homogenates. Toxicol Appl Pharmacol 21:275–85
  • Grundlingh J, Dargan PI, El-Zanfaly M, et al. (2011). 2,4-Dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death. J Med Toxicol 7:205–12
  • Haley MV, Kuperman RG, Checkai RG. (2009). Aquatic toxicity of 3-nitro-1,2,4-triazol-5-one. Available from: http://www.dtic.mil/dtic/tr/fulltext/u2/a508035.pdf [last accessed 1 Jul 2013]
  • Le Campion L, Delaforge M, Noel JP, et al. (1997). Metabolism of 14C-labelled 5-nitro-1,2,4-triazol-3-one by rat liver microsomes – evidence for the participation of cytochrome P-450. Eur J Biochem 248:401–6
  • Lent E. (2012). The subchronic oral toxicity of 2,4-dinitroanisole (DNAN) in rats. Aberdeen Proving Ground (MD): U.S. Army Public Health Command
  • Loomis WF, Lipmann F. (1948). Reversible inhibition of the coupling between phosphorylation and oxidation. J Biol Chem 173:807--8
  • Miranda EJ, Mcintyre IM, Parker DR, et al. (2006). Two deaths attributed to the use of 2,4-dinitrophenol. J Anal Toxicol 30:219–22
  • Paine MF, Hart HL, Ludington SS, et al. (2006). The human intestinal cytochrome P450 “pie”. Drug Metab Dispos 34:880–6
  • Pinchot GB. (1967). The mechanism of uncoupling of oxidative phosphorylation by 2,4-dinitrophenol. J Biol Chem 242:4577–83
  • Reddy G, Song J, Kirby P, et al. (2011). Genotoxicity assessment of an energetic propellant compound, 3-nitro-1,2,4-triazol-5-one (NTO). Mutat Res 719:35–40
  • Robert TA, Hagardorn AN. (1983). Analysis and kinetics of 2,4-dinitrophenol in tissues by capillary gas chromatography–mass spectrometry. J Chromatogr 276:77–84
  • U.S. Army. (2011a). Memo: Preliminary Occupational Exposure Level (OEL) for 2,4-dinitroanisole. Aberdeen Proving Ground (MD): Public Health Command
  • U.S. Army. (2010). Picatinny Public Affairs: army approves safer explosives to replace TNT. Available from: http://www.army.mil/article/43553/ [last accessed 1 Jul 2013]
  • U.S. Army. (2011b). Revised preliminary occupationa exposure level for 3-nitro-1,2,4-triazol-5-one (NTO). Aberdeen Proving Ground (MD): Public Health Command
  • U.S. Department of Defense. (2003). DODD 5000.1 Defense Acquisitions System. [online]. Available from: https://acc.dau.mil/CommunityBrowser.aspx?id=44888 [last accessed 1 Jul 2013]
  • U.S. Federal Government. (2001). 10 USC 2389 Ensuring safety regarding insentive munitions. Available from: http://cats.informa.com/PTS/proof/external/prepareCorrectionsFrames.do?nopopup=true&manuscriptId=829522&t=MANUSCRIPT [last accessed 1 Jul 2013]
  • van Herwaarden AE, Van Waterschoot RA, Schinkel AH. (2009). How important is intestinal cytochrome P450 3A metabolism?. Trends Pharmacol Sci 30:223–7
  • Williams LR, Adams VH, Wallace SM, et al. (2012). Toxicologic characterization of a novel explosive, guanidinium 3,4-dinitropyrazolate (GDNP), in female rats and Ames mutagenicity assay. Int J Toxicol 31:441–53
  • Yen M, Ewald MB. (2012). Toxicity of weight loss agents. J Med Toxicol 8:145–52

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.